Peer Review History
| Original SubmissionApril 23, 2020 |
|---|
|
PONE-D-20-11571 Deep learning in diagnosis of mastoiditis using multiple mastoid views PLOS ONE Dear Dr. Ryoo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Aug 02 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Yuchen Qiu, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This article compared the diagnostic performance of mastoiditis with Squeeze-and-Excitation Networks(SENet) trained by single view radiographic images with that trained by multiple view images and with radiologists' rating. The reference standards are the two radiologists' rating on plain radiography. Because the specificity of diagnosing mastoiditis is low on the plain radiography, the authors also provide the testing results based on radiologists' rating from CT images. The algorithms trained on 4139 patients and tested on three testing sets and showed the SENet trained on by multiple views images achieved better performance than that trained by single view images. Compare with reference standard from CT, the SENet showed similar sensitivity with radiologists and higher specificity than radiologists. However, the authors need to find similar literature as benchmarks to compare the performance. Authors write all data are fully available without restriction. How about the image data and labels? The title is too general. Line 3 add anteroposterior (AP) Line 9 add case numbers for training and validation sets. Line 15 add AUC values Rephase the sentence on line 22. Line 43 This also contributes to a tremendous increase in radiologists’ work loads. What is this refer to? Line 66 What is the inclusion criteria in detail? Do somehow mastoiditis need a screening? Why the mastoid series didn't include any other diseases? What are the criteria for those patients underwent TB CT after radiography? Do you think those patients' plain radiographic images are different from the rest? What if the two radiologists labeled different? Show kappa coefficients between two radiologists for each dataset. Why I.R. and L.S. instead of H.N.J. label the gold standard test set again or for CT instead of radiographic? How to get the final consensus? It seems I.R. read both CT and plain radiography. In the gold standard testing set, you made two types of labels, plain radiographic one and CT one. Please express clearly. And clarify it for each AUC result of gold standard testing set. Line 102 Show a typical case for each category. LIne 122 Why did 120*180 mm resize to 384*256 pixels? How do you determine the center point? Is there any outliers? Line 126 Do horizontal and vertical shift on the original image or on the cropped image with zero paddings? Line 130 add CPU GPU types and memories. Draw the network architecture of single and multiple views, especially showing the difference of inputs. For single view, learning rate decayed every 5000 steps at the rate of 0.94 with the initial value of 0.01. While those parameters change to 1000, 0.04, 0.005. Please explain the reason, or add new experiments to evaluate the parameter effects. The batch size is normal to set as 32,64,128 etc instead of 12. The pediatric group is the most common. Age with mean and sd in table 1 are not good metrics. Maybe use percentage for each age group. Clarity what the Deep learning algorithm is in table 3, multi-views or single-view? The authors use the cut-off point at which sensitivity was 95%, and the cut-off point at which specificity was 95%. However, in the table 3 and 4. the metrics are not 95%. Redesign table 4. It is hard to read. Maybe put sensitivity and specificity together for each point. Which dataset is the images of Fig4 from? I think using gold-standard testing set is better due to the CT labels. Line 372 typo "rained". The authors did not show location results for "deep learning algorithm depicted the exact location of diseased mastoid air cells". Some selected images in Fig4 are not enough. Line 375 rephase similar to superior... to Reviewer #2: The authors had presented a study to compare the diagnostic performance of deep learning algorithm trained by single view or multiple views. They evaluate the performance of the algorithms trained by the two strategies and also compared those trained algorithms with expert manual diagnostic performance. The conclusion of the study is that the deep learning algorithm trained by multiple views perform better than algorithms trained by single view. Also the algorithms trained by multiple views can achieve similar (or even better) performance than the radiologists. The conclusion drawn by the authors are meaningful, but the first part of the conclusion is predictable without the study. As stated by the authors, in practical, manual procedure would use multi-view instead of single view. Meanwhile, the accuracy of algorithms trained by using multi-view would be expected to outperform algorithms trained by using one single view. According to the ROC curves shown by the authors, even though the performances are significantly different according to statistical analysis , the accuracy numbers are not that different. The authors have done thorough statistical analysis to support its claims. However, I believe the authors should clearly discuss the innovation or significance of this study. Currently, the paper gave out a signal that it proved an well-expected conclusion and there is limited to none innovation in the methodologies. This is a bit difficult to justify the significance of the work. The paper is not well organized. Repetitive contents show up a lot. For instance, page 6, line 94-101 are repetitive. The paragraphs before Conclusion section are also poorly organized. The authors should re-organize the paper. One minor question: In page 8, why are the learning rate of the two CNN with very different decay rate (0.94 vs 0.04) and initial value (0.01 vs 0.005)? Reviewer #3: This manuscript explores mastoiditis classification with multiple view and single view and the comparison with radiologists. The manuscript is easy to understand and well-written. However, several limitations and points for further clarifications are listed below: 1. Why using the patients w/ TB CT as the gold standard test set? Is there a diagnostic accuracy difference compare to multiple view? If yes, what’s the accuracy difference? 2. The gold standard test set labeling is not clearly described in Page 6, line 94-101. Only until I read the result section, I start to realize how the labeling was conducted for the gold standard test set. I was confused by line 94 and line 100, as there are two types of labeling descriptions. Maybe the authors state ahead of that the gold standard test set was labeled twice, one was based on the concurrent TB CT by I.R. and H.N.J., the other time was based on mastoid series like in the training/validation set by I.R. and L.S.. Same for describing the labeling criteria for gold standard test set in Line 102-113, it is confusing that at the beginning saying “all the image in the dataset were labeled according…” and later on saying that “The gold standard test sets were labeled as … according to the results of TB CT.” 3. How to control if the two neuroradiologists have different opinions on the same patient, and what if the labeling is different based on TB CT and mastoid series for the gold standard test set? Which one should be used as the final classification label? 4. The deep learning method in Page 8 is not clearly described. How were the CNNs combined with multiple views? A structure figure is suggested for better illustration. Is that the CNN model is trained for each view respectively first, and further to average the last SE-ResNet module’s Log-Sum-Exp pooling values for all individual views to build the multiple view model? Is there a finetuning for the multiple view model? If yes, how did it conducted? If due to page/word count limitations, please include the details in a supplementary file. 5. In Table 1. the authors should give the full description of the abbreviations as notes. What does “CR” stands for? Please use a dash “-” to indicate the content is not available. The labels are different based on different imaging (CR and TB CT). Which is the final label of the gold standard test set, based on CR or CT? (refer to Question #3). 6. The notations of Figure 4 are not clear, I’m assuming the left side is the input image, and the right side is the outputs based on the attentions. It will be much clear if the authors can circle/point out where the lesions are in true positive (a), false negative (d), and postoperative state (e). 7. It’s suggested to provide the confusion matrix like in Fig.2 but for based on the mastoid series. 8. A normal/abnormal case is based on an individual patient or an individual ear? Is diagnostic accuracy calculated as ear-based or patient-based? If one patient has both ears as otomastoiditis, how can the authors determine the classification accuracy if the results show one ear is positive and another ear is negative? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-11571R1 Performance of deep learning to detect mastoiditis using multiple conventional radiographs of mastoid PLOS ONE Dear Dr. Ryoo, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 24 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Yuchen Qiu, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The author partially address my concerns. The revision on the main text should be as important as comment response. The authors claim: “because the most commonly affected age group is the pediatric group, especially patients under two years old who are very sensitive to radiation exposure, simple radiography still has its role.” But the age distribution in table 1 is not the case. 50-59 year-old patients contribute the most. Less than 20 year-old patients is minor, only around 8%. This compromised the novelty. Please explain it. “Deep learning algorithm depicted the exact location of diseased mastoid air cells.” The activation map of diseased mastoid air cells is a key contribution of this article. However, this article lacks of the detail implement of activation map in the method. Please add it. Please provide a reference for the claim of “Simple radiographies take a large portion of radiologists’ work-loads.” (L47-48) R1-8:Line 66 What is the inclusion criteria in detail? Do somehow mastoiditis need a screening? Why the mastoid series didn't include any other diseases? --> Mastoid series were usually performed for screening mastoiditis (infection/inflammation) before operations such as organ transplantation and cochlear implantation. In those cases, preoperative treatment of mastoiditis is very important. (immunosuppresants will be used in patients after organ transplantation surgery, cochlear implant electrodes will go through mastoid air cells in cochlear implant op) Also, mastoid series were also performed in patients with suspected mastoiditis. (L69) Mastoid series were used for detecting mastoiditis. Other diseases are very rare in mastoid air cells and also even those rare diseases (such as tumorous condition) are usually presented as mastoiditis patterns in imaging. Please add this background information to the paper. Actually majority of cases in gold standard test sets (which have both mastoid series and TB CT) performed TB CT and mastoid series simultaneously. Please add this response to the paper. L96 please revise to labels were determined by consensus after the two radiologists discussed. It seems I.R. read both CT and plain radiography.Yes. However, labeling TB CT and labeling radiographs were performed separately (blinded). When labeling the plain radiographs of gold standard set by I.R., those plain radiographs (around 800 image sets) were randomly mixed with other 9,000 images in training/validation sets. Please add this response to the paper. The left/right center points in the AP view are the points annotated in the image below. Outliers are excluded from the analysis.(L135) Please add this response to the paper. R1-16:Line 126 Do horizontal and vertical shift on the original image or on the cropped image with zero paddings? --> Horizontal and vertical shift were used in the training process. The authors didn’t answer this question. Image shift will result in black edge. Shifting on the original image before cropping will replace the black edge with the pixels adjacent to the edge. Did you do it on the original image or on the cropped image? Reviewer #3: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Jingchen Ma Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Performance of deep learning to detect mastoiditis using multiple conventional radiographs of mastoid PONE-D-20-11571R2 Dear Dr. Ryoo, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yuchen Qiu, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have addressed my comments. Now the paper is in good shape. I suggest to accept this paper. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No |
| Formally Accepted |
|
PONE-D-20-11571R2 Performance of deep learning to detect mastoiditisusing multiple conventional radiographs of mastoid Dear Dr. Ryoo: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yuchen Qiu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .